Career Opportunities
Center Director Position
Director: Center for Metabolic and Degenerative Diseases
THE INSTITUTE OF MOLECULAR MEDICINE | University of Texas Medical School- Houston
The Brown Foundation Institute of Molecular Medicine (IMM) in the University of Texas Medical School at Houston is a translational research institute that investigates the cause of human diseases at the genetic, cellular and molecular level. We invite applications for the position of Director of the Center for Metabolic and Degenerative Diseases (MDD), one of eight research centers within the IMM. The appointment will be at Associate / Full Professor level on the tenure track. Candidates should have an established, well-funded independent research program that has significant overlap with ongoing-research in MDD, and be able to leverage collaborative interactions with other IMM research centers. Applicants will be expected to have a track record of successful academic leadership. Responsibilities will include expanding and increasing the international profile of MDD.
Applicants using innovative in vitro or animal model systems to study the underlying mechanisms of metabolic diseases such as diabetes, or neurodegenerative diseases such as muscular dystrophy, Alzheimer’s, Parkinson’s, or other related disorders will be given preference. Applicants with appropriate medical qualifications will have the opportunity of a joint appointment within the division of Endocrinology in the Department of Internal Medicine.
The IMM (http://www.uthouston.edu/imm/) has outstanding research facilities and is located within the Texas Medical Center, which includes UT-Health Sciences Center, Baylor College of Medicine and M.D. Anderson Cancer Center. An attractive start-up package and competitive salary and benefits will be provided.
To apply, please fill-out application on-line @http://jobs.uth.tmc.edu, Requisition #130808.
- You will need to attach your Curriculum Vitae
- A letter that addresses the position criteria
- A brief description of future research plans
- Contact details of three referees
Letters should be addressed to: Dr. John F. Hancock, Executive Director, the Brown Foundation Institute of Molecular Medicine, University of Texas Medical School at Houston. Review of applications will begin immediately and will continue until the position is filled.
The University of Texas is an Equal Opportunity Employer and encourages applications from women and minorities.
Assistant Professor Position
Texas Therapeutics Institute
THE INSTITUTE OF MOLECULAR MEDICINE | University of Texas Medical School- Houston
The Brown Foundation Institute of Molecular Medicine (IMM) in the University of Texas Medical School at Houston is a translational research institute that investigates the cause of human diseases at the genetic, cellular and molecular level. We invite applications for a chemistry faculty position at the Texas Therapeutics Institute (TTI), one of eight research centers within the IMM.
The appointment will be at the Assistant Professor level on the tenure track. The candidate will be expected to develop an independently supported research program that applies synthetic and natural product organic chemistry techniques to design methods for the synthesis of therapeutic compounds, to solve lead molecule optimization problems, to prepare molecules with novel chemical or biological properties or to enhance structural diversity. There will be extensive opportunities for collaboration with IMM scientists working in diverse areas of biology. Some background in basic understanding of cancer biology, enzymology, pharmacology, pharmacokinetics, and molecular modeling would be beneficial. Applicants will have the opportunity of a joint appointment within the Department of Nanomedicine and Biomedical Engineering, or the Department of Integrative Biology and Pharmacology.
The IMM (http://www.uthouston.edu/imm/) has outstanding research facilities and is located within the Texas Medical Center, which includes UT-Health Sciences Center, Baylor College of Medicine and M.D. Anderson Cancer Center. An attractive start-up package and competitive salary and benefits will be provided.
To apply please fill-out application on-line @ http://jobs.uth.tmc.edu, requisition #130969.
You will need to attach the following:
- You will need to attach your Curriculum Vitae
- A letter that addresses the position criteria
- A brief description of future research plans
- Contact details of three referees
Letters should be addressed to: Dr. Zhiqiang An, Director of the Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, University of Texas Medical School at Houston
Review of applications will begin immediately and will continue until the position is filled. The University of Texas is an Equal Opportunity Employer and encourages
Center for Metabolic and Degenerative Diseases
Postdoctoral Positions
Post-doctoral positions are available in the laboratory of Dr. Vihang Narkar at the Center for Metabolic and Degenerative Diseases, Institute of Molecular Medicine, University of Texas Medical School at Houston. The successful candidate will use a combination of molecular biology, tissue culture, immuno-histochemistry and mouse genetic engineering to study transcriptional signaling in skeletal muscle-linked diseases such as diabetes and muscular dystrophy. Desirable candidates will have a recent Ph.D. in biological sciences, will be highly motivated and innovative, and have research expertise in transcriptional regulation and/or muscle physiology, as demonstrated by first-author paper(s) in peer-reviewed journals.
Interested candidates should email a cover letter describing research goals, CV and a list of three references to (Please indicate POST-DOCTORAL APPLICANT in the email subject):
Vihang A. Narkar, Ph.D.
Assistant Professor
Center for Metabolic and Degenerative Diseases
Institute of Molecular Medicine
University of Texas Medical School at Houston
Email: vihang.a.narkar@uth.tmc.edu
Website: http://www.uthouston.edu/imm/profile.htm?id=1402137
UTHealth is an Equal Opportunity Employer: M/F/D/V. This is a security sensitive position and thereby subject to TX Edu. Code Section 51.215. A background check will be required for the final candidate.
Center for Stem Cell and Regenerative Medicine
Postdoctoral Position
Open for projects converging on the biology of cancer, stem cells, and adipose tissue, as well as on preclinical targeting of pathological cell populations with experimental therapeutics. Strong expertise in cell / molecular biology / biochemistry is required. Preference will be given to candidates with experience in genetic mouse model and clinical sample analysis.
Personal statement, CV, and letters of reference should be submitted to:
Mikhail Kolonin, Ph.D.
Associate Professor, John S. Dunn Research Scholar
Jerold B. Katz Distinguished Professor in Stem Cell Research
The Brown Foundation Institute of Molecular Medicine
Center for Stem Cell and Regenerative Medicine
University of Texas Health Science Center at Houston
1825 Pressler st., Rm. 630-G, Houston, TX 77030
Office: 713-500-3146 | FAX 713-500-2424
Click here to email Dr. Mikhail Kolonin
UTHealth is an Equal Opportunity Employer: M/F/D/V. This is a security sensitive position and thereby subject to TX Edu. Code Section 51.215. A background check will be required for the final candidate.
Center for Stem Cell and Regenerative Medicine
Postdoctoral Positions
Center for Stem Cell and Regenerative Medicine Brown Foundation Institute of Molecular Medicine
UTHealth has 3-4 positions available in the laboratory of Brian R. Davis, Ph.D., Associate Professor
Interim Director of Center for Stem Cell and Regenerative Medicine.
Successful candidates for these positions are as follows:
1) have received Ph.D. in Biological/Physical/Chemical Sciences within the last 5 years
2) have significant prior experimental experience in molecular and cellular biology
3) have strong analytical and quantitative reasoning skills
4) have the intellectual capacity, work ethic, creativity, writing skills, and motivation to pursue an independent academic research career
5) be able, upon request, to provide two letters of reference.
No phone calls please. Interested applicants should send a cover letter stating their research interests, a curriculum vitae, and relevant reprints to:
email to: brian.r.davis@uth.tmc.edu.
The cover letter should address each of the five criteria enumerated above.
Dr. Davis’ laboratory has as its primary focus the genomic editing of chromosomal DNA in stem cells – utilizing homologous recombination processes to restore an endogenous mutant gene sequence to the corrected normal sequence in autologous stem cells obtained from patients with inherited genetic disease. This work has largely focused on induced pluripotent stem (iPS) and hematopoietic stem cells. Current diseases under investigation include those affecting the lung (Cystic fibrosis, Surfactant Protein B Deficiency) and blood (Wiskott-Aldrich Syndrome). A second line of investigation is focused on spontaneous somatic reversion of inherited mutations or “natural gene therapy” in patients with inherited genetic disease.
The Center for Stem Cell and Regenerative Medicine occupies the 6th floor of the Sarofim Research Building, a state-of-the-art facility in the Texas Medical Center fully equipped for molecular research.
The University of Texas is an EO/AA employer. M/F/D/V. This is a security-sensitive position and thereby subject to Texas Education Code §51.215. A background check will be required for the final candidate.
TEXAS THERAPEUTIC INSTITUTE
Positions for postdoctoral fellows to study novel molecular mechanisms of cancer metastasis are available in Dr. Wenliang Li’s lab at the Institute of Molecular Medicine (IMM) of UTHealth-Houston.
Metastasis is responsible for over 90% of cancer death but its mechanisms are still poorly understood. Research in Dr. Li’s lab is to identify and study novel regulators of cancer metastasis, cancer stem cell, epithelial-mesenchymal transition (EMT), and drug resistance through a unique combination of RNAi/cDNA screens, cancer genomics, molecular cell biology, mouse models and patient specimens. The goals of the research are to gain new knowledge of metastasis and to identify novel cancer drug targets for the development of better therapeutics.
Qualified candidates should have a doctoral degree, strong background and good first-author publications in cancer biology, molecular cell biology, or signal transduction. Prior experience in mouse xenograft models is desirable but not required. The postdoc fellows are expected to have strong work ethic, high self-motivation, critical thinking abilities, excellent organizational and communication skills.
For those interested, please send a CV, contact information of three references, and a brief research statement describing past achievements, skills and research interests to Dr. Wenliang Li at email at: wenliang.li@uth.tmc.edu.
Faculty Profile:
Dr. Wenliang Li
TEXAS THERAPEUTICS INSTITUTE at
UTHealth - Houston
The Brown Foundation Institute of Molecular Medicine
for the Preventative of Human Diseases
1825 Pressler Street
Houston, TX 77030
The University of Texas is an EO/AA employer. M/F/D/V. This is a security-sensitive position and thereby subject to Texas Education Code §51.215. A background check will be required for the final candidate.
TEXAS THERAPEUTIC INSTITUTE, IMM
The Texas Therapeutics Institute (TTI) at the Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, is at the forefront of translation research in identifying drug targets and discovering potential therapeutics for cancer treatment. Our research is focused on understanding the function and signaling mechanisms of ligand-receptor systems that play fundamental roles in the control of growth, proliferation, and migration of cancer cells as well as the self-renewal and differentiation of cancer stem cells. Our approach to drug discovery is to generate and validate antibodies against targets that are essential to cancer cell survival and then demonstrate robust efficacy in tumor models. We are equipped with state-of-the-art facilities and instruments to carry out cutting edge research of in vitro and in vivo studies. Our faculties are highly experienced and successful in drug discovery and development.
Post-doctoral positions are available in the laboratories of Drs. Zhiqiang An and Qingyun (Jim) Liu at TTI to study mechanism of signaling transduction of ligand-receptors systems in cancer cells and obtain training in drug discovery and development. Successful candidates must have received Ph.D. within 2 years in the field of cell biology, cancer biology, pharmacology, or biochemistry with first author publications in leading journals. They must also have strong skills in molecular biology and tissue culture, and the intellect, creativity, and writing skills to pursue a successful research career in academia or industry.
Interested candidates should email CV and at least one letter of references to qingyun.liu@uth.tmc.edu or to zhiqiang.an@uth.tmc.edu.
FACULTY PROFILES
Zhiqiang An, Ph.D
Qingyun (Jim) Liu, Ph.D.
TEXAS THERAPEUTICS INSTITUTE at
UTHealth - Houston
The Brown Foundation Institute of Molecular Medicine
for the Preventative of Human Diseases
1825 Pressler Street
Houston, TX 77030
The University of Texas is an EO/AA employer. M/F/D/V. This is a security-sensitive position and thereby subject to Texas Education Code §51.215. A background check will be required for the final candidate.
